Pegaspargase In The Treatment of Acute Lymphoblastic Leukemia- A CMA Model Demonstrates Its Economic Benefit For The Italian National Health System
Abstract
Authors
M Faiella C Lecureuil U Staginnus S Robbins
M Faiella C Lecureuil U Staginnus S Robbins
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now